RSS Feeds
Search

Companies

Companies

Displaying 1..10 of 13 - per page Next page
Order by
NorthShore University HealthSystem Research Institute
NorthShore University HealthSystem Research Institute More
National Research Council Biotechnology Research Institute
NRC-BRI's Health and Bioprocess Sectors promote and conduct innovative collaborations, services and technology transfers with the biotechnology and pharmaceutical industries. More
The University of Edinburgh
The University of Edinburgh has an international reputation for world-class research in medicine and biotechnology. More
Bioneer A/S
Bioneer is a CRO research based company within recombinant protein production, immuno-regulatory assays, drug characterization and formulation and diagnostic biomarkers. More
LeadDiscovery Ltd
LeadDiscovery offers intelligence services to the drug discovery sector. Focusing on pre-clinical research and analysis for identification and development of new therapeutic entities More
Sage Healthcare Group
Zapaloid uses proprietary technology to develop innovative disease-modifying therapeutic strategies against protein misfolding diseases, such as Type 2 diabetes, Parkinson's and Alzheimer's disease More
Ed Bertolas associates
I am a recruiter in the life science industry. My company has been in business for 29 years and has "Placed" over 450 people in the medical arena. More
Cerca Insights Sdn Bhd
Discover MORE! Cerca Insights is a Malaysian based CRO focused on behavioural pharmacology More
Fluofarma
High Content Screening Services More
Chakra Biotech Pte Ltd
Chakra Biotech More
Displaying 1..10 of 13 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Epigenetics: Current and future applications that are driving novel drug discovery
Aug 2010 - 80 pages - $1,215
Advanced Oral & Parenteral Drug Delivery Technologies Players, Products & Prospects to 2015
Jan 2011 - 124 pages - $1,740
The Drug Discovery Outsourcing Market
Jan 2011 - 99 pages - $3,835
Biomarkers: Applications and Trends
Aug 2010 - 138 pages - $1,215
Glazer’s Wholesale Drug Company, Inc.: SWOT Analysis & Company Profile
Sep 2010 - 15 pages - $99
Leading Drug Delivery Companies and Technologies
Jun 2008 - 175 pages - $3,835
Drug Delivery Technologies: Players, products & prospects to 2018
Jun 2009 - 472 pages - $3,140
Glazer's Wholesale Drug Company Inc. - SWOT Analysis
Dec 2010 - 21 pages - $125
Turner Drug Store Ltd. - Company Capsule
Aug 2011 - 7 pages - $75
Gilead’s newly approved drug Complera, the Second Triple Combination Once-a-Day Pill Intended for Untreated HIV Patients is unlikely to displace its own market-leading drug, Atripla
Aug 2011 - 5 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us